European clinical trial starts on possible coronavirus treatments

COVID-19, coronavirus
This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient, emerging from the surface of cells (blue/pink) cultured in the lab. Credit: NIAID-RML
A European clinical trial involving some 3,200 people has been launched to test four possible experimental treatments against the coronavirus.

The four treatments to be studied are remdesivir, lopinavir and ritonavir in , the latter being administered with or without and hydroxychloroquine, French public health research body Inserm said in a statement on Sunday.

People taking part in the study will have been hospitalised with COVID-19 infection and are expected to be drawn from Belgium, Britain, France, Germany, Luxembourg, Spain and the Netherlands, the statement said.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2020 AFP

Citation: European clinical trial starts on possible coronavirus treatments (2020, March 22) retrieved 14 August 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors